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Summary: The global scenario is now supporting the development of modern drugs from less toxic plant 
products with proven medicinal properties. Each part of neem plant (Azadirachta indica A. Juss) reportedly 
has various medicinal properties and has been in use in many continents for centuries. Recently, a 
fractionated neem-leaf extract known as IRAB with reported activities against Malaria, HIV/AIDS and 
cancer has been developed into a drug and currently marketed in Nigeria as IRACAP®.  This paper reviews 
the medicinal properties, clinical studies and safety concerns of this fractionated acetone-water neem leaves 
extract as a footstep to further studies both on the extract and/or its chemical constituents. 
Key words: IRAB, dogonyaro, Malaria, Nigeria 
 
Introduction 
Extracts  from neem tree (Azadirachta indica A. 
Juss) also called “dogonyaro” in Nigeria are most 
consistently recommended in ancient medical texts 
for gastrointestinal upsets, diarrhea and intestinal 
infections, skin ulcers and infections, and malaria 
(Schmutterer,1995). India encouraged scientific 
investigations of neem tree as part of his program to 
revitalize Indian tradition and also increase 
commercial interest on neem (Stix, 1992) and 
presently  some authors believe that no other plant or 
tree in the world has been so extensively researched 
or used, in all possible capacities so far. In Africa 
extracts from Neem leaves have provided various 
medicinal preparations (Ekanem, 1971 and Udeinya, 
1993). A fractionated acetone-water extract also 
known as IRAB has been showing safer medicinal 
properties (Mbah et al, 2007). In-vitro studies with 
malaria-infected erythrocytes and metastatic cancer 
cells had earlier shown that IRAB has broad-
spectrum anti-cytoadhesion activity which has been 
beneficial in HIV/AIDS (Udeinya et al, 2004). Mbah 
et al (2007) reports IRAB as safe and able to increase 
CD4+ cell levels in HIV/AIDS patients.  
Extraction, fractionation, Chemical components of 
Nigerian neem leaf extract (IRAB) 
Fractionated neem leaves extract with registered 
U.S. Pat. No. 5,370,873 issued Dec. 6, 1994 (also 
known as IRAB) is registered and marketed in 
Nigeria in 250mg capsules as IRACARP® 
(NAFDAC Registration number A7-0319L). 
Extraction is done using neem leaves collected in 
Nigeria in a mixture of acetone and water (1:1, by 
vol.) as described by Udeinya (1993). Residue from 
the bottom layer of the crude extracts is then 
fractionated by standard, high-performance liquid 
chromatography (HPLC) (Udeinya et al, 2006). The 
end product (IRAB) is a complex molecule (202 
Daltons) with functional groups that include sodium 
salts of carboxylic acid and a non-aromatic dialcohol 
(Mbah et al, 2007). 
 
Reported medicinal actions of IRAB: 
In-vitro and in-vivo studies on IRAB have 







Extracts from Nigerian neem leaves 
(Azadirachta indica) have been earlier reported to 
have anti-malarial activities (Ekanem, 1971), but 
Udeinya (1993) demonstrated that acetone/water 
mixture is a more efficient solvent than water alone 
for the extraction of anti-malarial activity from 
Nigerian neem leaves. This activity has been 
reportedly retained by IRAB (Udeinya et al 2006 and 
2008). Its anti-malarial activity has been reported to 
be superior to chloroquine (Udeinya et al, 2006), 
gametocytocidal. (Udeinya et al, 2006 and 2008) and  
schizonticidal (Udeinya 2008) against faliciparium 
malaria parasite. Indeed Anyaehie (2009) reported 
anti-pyrexial activity among Nigerians where malaria 
remains the commonest cause of Fever. Patients from 
malaria are also likely to benefit from reported anti-
cytoadhension property of IRAB since adhesion of 
infected erythrocytes to the endothelium is key factor 
in pathogenesis of severe falciparium malaria (David 
et al, 1983). 
 
Anti-retroviral: 
Udeinya et al (2004) first reported anti-
retroviral activity by IRAB on patients with 
HIV/AIDS in a phase I clinical trial. In another study 
by Mbah et al  (2007) that lasted 12 weeks, IRAB 
was administered (1g daily) to 60 patients infected 
with HIV-1 & 11. The results showed a significant 
increase from the baseline mean CD4
+ 
cell count of 
266 cells/ul by week 12.  Mean body weight and 
hemoglobin concentration were also significantly 
increased.  Opportunistic infections and other 
HIV/AIDS related conditions were reportedly 
completely resolved in most patients by week 12. 
Also, the erythrocyte sedimentation rate (ESR) was 
reported to have been significantly decreased from a 
baseline mean value of 64mm/hr to 16mm/hr.  
Anyaehie (2009) compared the anti-retroviral 
properties of IRAB with that of highly active anti-
retroviral therapy (HAART) and results are 
consistent with Mbah et al (2007) after 16weeks of 
therapy. However, Anyaehie (2009) documented a 
more significant increase in CD4+ cells and 
elimination of skin rashes among patients on 
HAART compared to patients on IRAB. Mbah et al 
(2007) and Anyaehie (2009) agree that there was a 
significant improvement in patients’ condition with 
respect to presenting symptoms and physical 
examination findings. These reports of correction of 
CD4+ cell counts and improvement in patients’ 
clinical profile may indeed relate to corresponding 
reduction in viral activity and led to a presumptive 
conclusion that the fractionated neem leaf extract 
(IRAB) is safe and increases CD4+ Cell Levels in 
HIV/AIDS patients, a conclusion the work of 
Anyaehie (2008) further supported. 
 
Are there any side effects or interactions? 
Neem leaf extracts appear to be very safe at 
recommended intake levels with no significant 
reports of problems.  Also, use of IRAB has 
consistently reported no adverse effects either as an 
anti-malaria (Udeinya et al, 2006 and 2008) or an 
anti-retroviral agent (Mbah et al, 2007 and Anyaehie 
2009). Water extracts of neem leaf have been shown 
to decrease blood levels of chloroquine in rabbits 
(Nwafor et al, 2003) but this has not been 
investigated with IRAB. The use in pregnancy has 
also not been evaluated and thus is not yet 
recommended. At the time of writing, there were no 
well-known drug interactions with IRAB. 
 




Development of modern non-toxic drugs from 
neem has earlier been suggested (Biswas et al, 2002) 
and IRAB represents such dream. This fractionated 
acetone/water neem leaf extract is the only drug 
reported to have activities against Malaria and 
HIV/AIDS. Recent in-vivo studies have substantiated 
the earlier in-vitro reports of pharmacological 
properties. The drug is reportedly safe, and thus 
further studies both on the extract and/or its chemical 
constituents are highly suggested to streamline these 
innovative findings into strategies for achieving the 
health components of the Millennium Development 
Goals (MDGs).  
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